Fundz

Eleven Therapeutics Welcomes Dr. Paloma H Giangrande as Chief Technology Officer

PRIVATEJan 11, 2024

Position

Chief Technology Officer

Company

Eleven Therapeutics

Paloma H Giangrande
paloma@eleventx.com
Tel AvivBiotechnologyHealth CareArtificial IntelligenceTherapeuticsMarket Research

Description

Eleven Therapeutics, a pioneering biotechnology company specializing in next-generation mRNA therapeutics, proudly announces the appointment of Dr. Paloma H Giangrande as the company's Chief Technology Officer .

Quick answer

Eleven Therapeutics Welcomes Dr. Paloma H Giangrande as Chief Technology Officer (January 11, 2024). Eleven Therapeutics is based in Tel Aviv, Tel Aviv District, Israel.

Who is the new Chief Technology Officer at Eleven Therapeutics?
Eleven Therapeutics named Paloma H Giangrande Chief Technology Officer, announced January 11, 2024.
What did Eleven Therapeutics announce on January 11, 2024?
Eleven Therapeutics, a pioneering biotechnology company specializing in next-generation mRNA therapeutics, proudly announces the appointment of Dr. Paloma H Giangrande as the company's Chief Technology Officer .
What does Eleven Therapeutics do?
Eleven Therapeutics ushers in the next generation of RNAi therapeutics by combining artificial intelligence (AI), massively parallel functional assays, and combinatorial chemistry.
Where is Eleven Therapeutics based?
Eleven Therapeutics is based in Tel Aviv, Tel Aviv District, Israel.
Which similar companies made leadership changes around the same time?
BPGbio (January 22, 2024), Paratus Sciences Corporation (February 21, 2024), Insitro (January 8, 2024) and Vera Therapeutics, Inc. (January 8, 2024) also announced leadership changes within 45 days of Eleven Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Market Research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Eleven Therapeutics, and when

A new leader at Eleven Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Eleven Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eleven Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eleven Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eleven Therapeutics

Location

Tel Aviv, Tel Aviv District, Israel

About

Eleven Therapeutics ushers in the next generation of RNAi therapeutics by combining artificial intelligence (AI), massively parallel functional assays, and combinatorial chemistry. Its flagship invention features a new modality, dubbed SCSI-RNATM (smart-combinatorial, small interfering RNA), a fully programmable molecule, rationally designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. Founded in 2020 by a group of globally-leading, interdisciplinary scientists, Eleven Therapeutics brings new RNAi therapeutics for patients in need by capitalising on some of the world's best pools of talent through its three collaborative hubs—in Cambridge, UK; Boston, U.S.; and Tel Aviv, Israel. Eleven is currently focusing its development pipeline on siRNA treatments for a range of respiratory diseases. To learn more, visit www.eleventx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eleven Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Paloma
Likely contact at this company
••••••••@••••••••

See Paloma's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Eleven Therapeutics's next move

Learn about Strategic plan

Eleven Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.